| 摘要 |
<p>The present invention relates in general, to arginine kinase (AK). In particular, the invention relates to a method of creating metabolic buffering for ischemic tissues and to a method of monitoring transgene expression. These methods involve the delivery of an AK gene into mammalian tissue, e.g., muscle or nervous tissue.</p> |
